Exozymes Inc (EXOZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | |
| Sales | 0 | 70 |
| Gross Profit | N/A | 70 |
| Operating Expenses | 5,932 | 1,866 |
| Operating Income | -5,932 | -1,796 |
| Other Income | 71 | -200 |
| Pre-tax Income | -5,861 | -1,996 |
| Income Tax | N/A | 42 |
| Net Income Continuous | -5,861 | -2,038 |
| Net Income | $-5,861 | $-2,038 |
| EPS Basic Total Ops | -0.89 | -0.33 |
| EPS Basic Continuous Ops | -0.89 | -0.33 |
| EPS Diluted Total Ops | -0.89 | -0.33 |
| EPS Diluted Continuous Ops | -0.89 | -0.33 |
| EPS Diluted Before Non-Recurring Items | -0.89 | N/A |
| EBITDA(a) | $-5,719 | $-1,651 |